Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Saw Palmetto, BPH Study Backed By $1.6 Mil. In NIDDK Funding

This article was originally published in The Tan Sheet

Executive Summary

Researchers at the University of California-San Francisco expect to complete enrollment for a study on the effects of saw palmetto in alleviating symptoms of benign prostatic hyperplasia (BPH) in June

You may also be interested in...



Saw Palmetto Efficacy For BPH Symptoms Slated For NIH Clinical Study

Three NIH divisions plan to spend a combined $29 mil. over the next seven years to study the efficacy of saw palmetto and Pygeum africanum on relieving symptoms associated with benign prostatic hyperplasia

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands

Topics

UsernamePublicRestriction

Register

PS093673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel